Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HEALTH ISSUES WILL BE OVERSEEN BY REP. BLILEY'S HOUSE COMMERCE COMMITTEE

This article was originally published in The Gray Sheet

Executive Summary

HEALTH ISSUES WILL BE OVERSEEN BY REP. BLILEY'S HOUSE COMMERCE COMMITTEE, according to a discussion draft of the new rules bill approved by the House Republican Conference on Dec. 7. The discussion draft states that the House Commerce Committee, now headed by Rep. Thomas Bliley (R-Va.), is the chief health issues panel, specifically responsible for "biomedical research and development" issues, "consumer affairs and consumer protection," and "health and health facilities, except health care supported by payroll deductions."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel